Marketable Securities

3 Months Ended

Mar. 31, 2022

Investments, Debt and Equity Securities [Abstract]

The Company has investments in certain debt securities that have been classified as available-for-sale and recorded at fair value. These investments are included in both assets for securities with a maturity of one-year or less and assets for securities with a maturity of more than one-year. These securities are held in the Insurance Company and shown as restricted given that the transfer of these assets is subject to the approval of the state regulators. As of March 31, 2022 (unaudited) and December 31, 2021, deposits with various states consisted of bonds, cash and cash equivalents with carrying values of $5.2 million in both periods.

Following the adoption of accounting guidance for credit losses on January 1, 2021, when marketable securities are in an unrealized loss position and the Company does not record an intent-to-sell impairment, the Company will record an allowance for credit losses ("ACL") for the portion of the unrealized loss due to a credit loss. Any remaining unrealized loss on a fixed maturity after recording an ACL is the non-credit amount and is recorded in other comprehensive income (loss) ("OCI"). The ACL is the excess of the amortized cost over the greater of the Company's best estimate of the present value of expected future cash flows or the security's fair value. The ACL cannot exceed the unrealized loss and, therefore, it may fluctuate with changes in the fair value of the fixed maturity if the fair value is greater than the Company's best estimate of the present value of expected future cash flows. The initial ACL and any subsequent changes are recorded in net realized capital gains and losses. The ACL is written off against the amortized cost in the period in which all or a portion of the related fixed maturity is determined to be uncollectible. For further information refer to Note 1, Basis of Presentation and Significant Accounting Policies in the Company’s 2021 Annual Report.

As of December 31, 2021 and March 31, 2022 (unaudited), the Company did not recognize credit losses.

The amortized cost and fair value of investments in fixed maturities classified as available-for-sale as of March 31, 2022 (unaudited) and December 31, 2021 are presented below (in thousands):


	As of March 31, 2022 (Unaudited)
	Amortized Cost		ACL		Unrealized Gain		Unrealized Loss		Estimated Fair Value
Marketable securities - restricted
Corporate debt securities	$	2,741	$	—	$	—	$	(3)	$	2,738
U.S. treasury and agency securities	40,088		—		—		(439)		39,649
Commercial paper	18,550		—		—		—		18,550
Asset backed securities	6,234		—		—		(22)		6,212
Total marketable securities - restricted	$	67,613	$	—	$	—	$	(464)	$	67,149


	As of December 31, 2021
	Amortized Cost		ACL		Unrealized Gain		Unrealized Loss		Estimated Fair Value
Marketable securities - restricted
Corporate debt securities	$	2,547	$	—	$	—	$	(2)	$	2,545
U.S. treasury securities	35,385		—		—		(104)		35,281
Commercial paper	16,081		—		—		—		16,081
Asset backed securities	8,728		—		—		(10)		8,718
Total marketable securities - restricted	$	62,741	$	—	$	—	$	(116)	$	62,625

The amortized cost and estimated fair value of marketable securities as of March 31, 2022 (unaudited) and December 31, 2021 and are shown below by contractual maturity (in thousands):


	As of March 31, 2022 (unaudited)
	Amortized Cost		Estimated Fair Value
Due within one year	$	52,471	$	52,298
Due between one to five years	15,142		14,851
	$	67,613	$	67,149


	As of December 31, 2021
	Amortized Cost		Estimated Fair Value
Due within one year	$	41,603	$	41,596
Due between one to five years	21,138		21,029
	$	62,741	$	62,625

The following table summarizes, for all fixed maturities classified as available-for-sale in an unrealized loss position at March 31, 2022, the aggregate fair value and gross unrealized loss by length of time those securities have been continuously in an unrealized loss position. The fair value amounts reported in the tables are estimates that are prepared using the process described in Note 2, Fair Value. The Company also relies upon estimates of several factors in its review and evaluation of individual investments, using the process described in Note 1, Basis of Presentation and Significant Accounting Policies in the Company’s 2021 Annual Report in determining whether a credit loss impairment exists.


	As of March 31, 2022 (unaudited)
	Less Than 12 Months				12 Months or Longer				Total
	Fair Value		Unrealized Losses		Fair Value		Unrealized Losses		Fair Value		Unrealized Losses
Marketable securities - restricted
Corporate debt securities	$	732	$	(3)	$	—	$	—	$	732	$	(3)
U.S. treasury and agency securities	39,649		(439)		—		—		39,649		(439)
Commercial paper	1,006		—		—		—		1,006		—
Asset backed securities	6,212		(22)		—		—		6,212		(22)
Total in an unrealized loss position	$	47,599	$	(464)	$	—	$	—	$	47,599	$	(464)


	As of December 31, 2021
	Less Than 12 Months				12 Months or Longer				Total
	Fair Value		Unrealized Losses		Fair Value		Unrealized Losses		Fair Value		Unrealized Losses
Marketable securities - restricted
Corporate debt securities	$	737	$	(2)	$	—	$	—	$	737	$	(2)
U.S. treasury and agency securities	31,809		(104)		—		—		31,809		(104)
Commercial paper	1,808		—		—		—		1,808		—
Asset backed securities	8,716		(10)		—		—		8,716		(10)
Total in an unrealized loss position	$	43,070	$	(116)	$	—	$	—	$	43,070	$	(116)